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Fatty liver disease in Sudan is not alcohol related 
Nail A M1 , Gadour MO2,  Khair MM3, Salma BM4, Suzan E5 
Abstract:  
Background: The finding of fatty liver disease (FLD) has generally been assumed to be a 
consequence of ethanol ingestion. However, non- alcoholic fatty liver disease (NAFLD) was 
identified as a specific entity. Although FLD is generally nonprogressive or only slowly 
progressive, cirrhosis and HCC can develop.  
Objectives: The aim of this study is to find out the prevalence, clinical presentation and 
aetiology of FLD in Sudanese patients. 
Methods: This is a descriptive cross sectional study which included 100 patients with FLD 
detected by ultrasonography at the national center for gastro-intestinal and liver diseases. 
Data was collected using a well designed questionnaire and results were analyzed by using 
SPSS computer system.  
Results: Out of 1800 patients with liver disease, 100 were found to have FLD. These have no sex difference. Thier 
mean age was 49.8 ±15.2 years. The main presenting symptoms were upper abdominal pain (60%) and fatigability in 
(41%). while (7%) were asymptomatic. Hepatomegaly was clinically detected in (44%). Ninety out of these 100 
patients had non alcoholic fatty liver disease (NAFLD).  In this group (42%) were diabetics and (55%) had 
hyperlipidemia. A BMI of > 25kg/m2 was detected in 47% of patients. In patients with FLD and a BMI <18kg/m2 
underlying diagnoses were made. Six patients had liver biopsy only two of them proved to have NASH. 
Conclusion: Fatty liver disease is not uncommon in Sudan and most of the patients’ diseases are non-alcohol related. 
 
Introduction 
Fatty liver disease (FLD) is a chronic 
disease that affects a high proportion of the 
world’s population. The finding of fatty liver has 
generally been assumed to be a consequence of 
ethanol ingestion. However, fatty liver can be due 
to metabolic diseases, medications and nutritional 
disorders. NAFLD was originally identified in 
morbidly obese individuals, especially after 
weight reduction surgery, and in diabetic women. 
It is now known that NAFLD also occurs in 
individuals who are not diabetics 1. It comprises a 
wide spectrum of liver damage ranging from 
simple, uncomplicated steatosis to advanced 
fibrosis and cirrhosis. Based on the morphologic 
pattern of liver injury in 20 patients evaluated at 
the Mayo Clinic over a 10-year period, Ludwig et 
al. 2 proposed a classification scheme for 
steatohepatitis that recognized the existence of a 
previously undescribed entity-non-alcoholic 
steatohepatitis(NASH)-, that was histologically 
identical to alcoholic hepatitis but had a different 
epidemiologic and clinical profile.  
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Non-alcoholic steatohepatitis (NASH) 
represents a stage within the spectrum of NAFLD 
and is defined histologically by the presence of 
fatty liver along with necroinflammatory activity 
mostly of lobular distribution 3.  
      The clinical implications of FLD are derived 
mostly from its common occurrence in the general 
population as well as its potential to progress to 
cirrhosis and liver failure. Fatty liver is found in 
approximately one third of autopsies in previously 
healthy adults who died as a result of accidents 
elsewhere 4. 
Fatty liver is defined as an accumulation of lipid 
in the liver exceeding 5% of liver weight, or 
visualization of more than 5% of hepatocytes 
containing fatty droplets on light microscopy 5.  
Acute fatty liver of pregnancy is a separate entity 
which is not discussed here. 
Objectives 
To determine how common is fatty liver disease 
in Sudanese patients, to study the etiology, the 
subtypes and presentation of this disease in 
Sudanese patients.  
Patients and methods 
This is a descriptive cross sectional study in 
Sudanese patients with FLD.  It was done at the 
National Centre of Gastrointestinal and Liver 
Diseases at Ibn Sina Hospital Khartoum, Sudan. 
Out of 1800 patients who had ultrasography for 
different liver diseases over a period of two years 
from Jan 2002 through Dec 2004, 100 cases were 
found to have FLD.  
Data of these patients was collected by a 
questionnaire and retrieving information from the 
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patients’ files. This was constructed in sections to 
address the different aspects of the study as 
follows: Personal data, presentation, physical 
examination and investigations including liver 
function tests, full blood count, mean corpuscular 
volume, lipid profiles and fasting blood sugar. 
The entire sample had an abdominal ultrasound 
examination by one radiologist. Liver biopsy and 
CT abdomen were done when indicated  
Data analysis: All the collected data was 
entered in a master sheet and fed to a statistical 
package for social sciences (SPSS Illinois 
Chicago)  
Results: 
Distribution of FLD to the subclasses: 
AFLD, Primary and Secondary NAFLD with their 
age distribution and BMI were shown in (table 1). 
Fifty- Five (55%) patients were female with male 
to female ratio of 1:1.2 while the ratio is 1: 3 and 
1: 1 in primary and secondary NAFLD 
respectively. 
Ninety (90 %) patients denied alcohol 
abuse. Presenting symptoms and signs were 
shown in (Fig 1).  Hepatomegaly was clinically 
detected in 44(44%) patients. Patients with 
primary NAFLD presented with right 
hypochondrial discomfort (75.6%), abdominal 





Fig1.Presenting symptoms in patients with FLD (n=100). 
 
In patients with FLD and BMI < 18 Kg/ m2 
other diagnoses were made (Table2). Liver 
function tests were performed for all patients. 
 In AFLD group all the 10 patients were 
males with mean age of 44.4±8.5. AST/ ALT > 1 
was detected in 6(60%), MCV > 100 FL in 
5(50%) patients. In NAFLD group (61%) were 
female with male to female ratio of I: 1.6. AST / 
ALT < 1 was found in (67.7%). 
Forty three (46.6%) of NAFLD group had 
primary NAFLD, 46 (51%) presented with 
secondary NAFLD, while one patient had no risk 
factor.        
 
Table2: underlying diagnoses in patients with 
BMI< 18kgs/m2 (n = 26) 
 
Diagnosis No % 
GI malignancy 11 42.3 
HIV 3 11.5 
TB 5 19.2 
Malabsorption 4 15.4 
IBD 3 11.5 
   
Risk factor for primary NAFLD were BMI 
> 25 Kg/m2 in (80%), NIDDM in (42.2%), 
Hyperlipidemia in (55%), Hypertention in (25%) 
and (62.8%) had more than 2 risk factors. 
Underlying diagnoses in patients with secondary 
NAFLD are shown in (Fig. 2). 
Thirty seven (37%) patients with FLD had 
gallstones on the ultrasound.  
In six patients liver biopsy was done as part 
of their work up, four had secondary FLD, two 
patients had primary NAFL, both of these two 
were overweight, had hepatomegaly, normal liver 
function tests, and they were not diabetic. One of 
them had hyperlipidemia in which liver biopsy 




Fig 2. Secondary causes of NAFLD (n=46). 
Discussion: 
    Fatty infiltration of the liver can be detected by 
ultrasonography or CT scan6. Because the fat 
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Table 1.   Age, Sex, BMI of different  groups of liver disease 
 
Seco. NAFLD Prim. NAFLD AFLD FLD Age 
M                F M                 F M              F   
2                  0 0                   0 0                0 2 1-19 
 
6                  6 2                   6 4                0 24 20-39 
 
6                  6 2                 14 5                0 33 40-59 
 
5                 11 14                 6 1                0 37 60-79 
 
4                   0 0                   0 0                0 4 >80 
 
47.8±24 53.14±14 44.4±8.5 - Age 
Mean ± SD 
18.9 28 20 - Mean of 
BMI 






          Table 3. Comparison of studies of patients with NAFLD 
 
Author n Age 
(Years) 
Female 
     (%) 
Diabetes 
      (%) 
Obesity 
      (%) 
Hyperlipidemia 
(%) 
Bacon (1) 33 47 42 21 39 21 
Ludwig(2) 20 54 65 50 90 67 
Lee (10) 49 53          78 51 69 NR 
Matteoni(11) 132 53 53 33 70 92 
Angulo(12) 144 51 67 28 60 27 
Diel(13) 49 52 81 55 71 20 
Powel (14) 42 49 83 36 95 81 
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distribution in the liver is uneven, the sensitivity 
of these imaging techniques for fatty infiltration is 
only 60%7, 8. However, this sensitivity may rise up 
to 80 to 90% when more than half the hepatocytes 
in an imaged region have macrovesicular fatty 
infiltration. Magnetic resonance imaging (MRI) 
using conventional spin-echo (SE) pulse 
sequences is relatively   insensitive9.  
To our knowledge, this is first study of 
FLD using ultrsonography done in Sudan.  
       The majority of patients with fatty liver are 
asymptomatic10. Some patients may come for 
evaluation of hepatomegaly, others present with 
mild abnormalities of the serum aminotransferases 
and alkaline phosphatase detected on routine 
visits to their physicians or detected incidentally 
by sonograms and/or a computed tomography 
(CT) scan performed to investigate other 
conditions. Fatty liver, however, can present with 
non-specific abdominal discomfort. In addition, 
patients with fatty liver of different etiologies will 
have systemic symptoms   and   signs related to 
their underlying disorders: in our patients the 
presenting symptom were more or less in 
accordance with that reported by Matteoni 11.  
The commonest underlying risk factors for 
FLD in the study population were similar to those 
reported earlier 1,2,10-14 (Table.3). 
Our study showed that gallstones are 
common with primary NAFLD, this may be an 
incidental finding due to the shared predisposing 
risk factors.     
In secondary NAFLD group the mean age, 
male to female  ratio and the underlying 
etiological causes were more or less in accordance 
with EL-Hassan5 et al. Hematological and non- 
hematological malignancies with or without liver 
involvement were the most frequently 
encountered etiological factors in (66%) of 
patients. 
     Liver biopsy is indicated in patients with 
enzyme elevations for more than 6 months 
duration, and changes in other liver tests, 
particularly if the symptoms and liver test 
worsen15. In addition, liver biopsy is indicated 
when there is doubt in the diagnosis or cause of 
the fatty liver12.  Only six of our patients fulfilled 
the pre-requisite criteria for liver biopsy. Out of 
these two had primary NAFLD. The biopsy 
confirmed NASH in only one patient with 
presentation similar to that reported by Ludwig in 
1980. NASH is diagnosed in 7 to 9 percent in 
Western countries and 1.2 percent in Japan2, 
16.This small number of biopsies might have 
underestimated NASH in our study. However, 
because liver biopsies are not without morbidities, 
we opted to proceed for it only once there was 
strong indication.  
Laboratory abnormalities in patients with FLD are 
usually minimal. The most common ones are mild 
elevation of the serum aminotransferases, alkaline 
phosphatase, or gamma glutamyl transpeptidase2. 
The number in AFLD group was small. 
This is probably due to the fact that alcohol 
consumption had been markedly decreased in the 
last 20 years in concordance with the 
governmental legislations. In addition, the 
Sudanese females do not usually consume alcohol 
as a habit. 
Overlapping of this group with groups of 
primary and secondary NAFLD was seen in four 
and two patients respectively. Distinguishing 
these was made only by history because alcohol 
markers in our study showed only sensitivity of 
50-60% in accordance with the literature17.  
Conclusion 
   Fatty liver disease, as determined by ultrasound, 
is not uncommon in Sudanese patients and in 
most of the cases is non-alcohol related. Future 
work is required to define the pathogenesis of this 
condition and plan effective management. 
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Al-Faisal specialized Hospital; an important new addition to modern medical services in Sudan.  
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